InMode (INMD) Depreciation & Amortization (CF) (2018 - 2026)
InMode's (INMD) quarterly Depreciation & Amortization (CF) came in at $175000.0 in Q1 2026, up 0.57% year-on-year from $174000.0 in Q1 2025, and up 0.57% quarter-over-quarter from $174000.0 in Q4 2025.
InMode (INMD) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
InMode has disclosed Depreciation & Amortization (CF) across 9 years of filings, most recently posting $175000.0 for Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $175000.0, up 0.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $696000.0 (down 5.56% YoY), and the FY2025 annual result was $695000.0, down 4.53% from the prior year.
- Depreciation & Amortization (CF) came in at $175000.0 for Q1 2026 at InMode, up from $174000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $248000.0 in Q4 2024 to a low of $122000.0 in Q4 2023.
- The 5-year median for Depreciation & Amortization (CF) is $174000.0 (2025), against an average of $170647.1.
- Across the five-year window, Depreciation & Amortization (CF) slumped 44.04% in 2023 and soared 103.28% in 2024, its largest moves.
- InMode's Depreciation & Amortization (CF) stood at $218000.0 in 2022, then plunged by 44.04% to $122000.0 in 2023, then jumped by 103.28% to $248000.0 in 2024, then dropped by 29.84% to $174000.0 in 2025, then advanced by 0.57% to $175000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $175000.0 (Q1 2026), $174000.0 (Q4 2025), and $156000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | InMode | 3.35 | -388.37 Mn | 61.55 Mn | 175,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 175,000.00 |
| Mar 31, 2026 | 175,000.00 |
| Dec 31, 2025 | 174,000.00 |
| Dec 31, 2025 | 174,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Jun 30, 2025 | 191,000.00 |
| Jun 30, 2025 | 191,000.00 |
| Mar 31, 2025 | 174,000.00 |
| Mar 31, 2025 | 174,000.00 |
| Dec 31, 2024 | 248,000.00 |
| Dec 31, 2024 | 248,000.00 |
| Sep 30, 2024 | 138,000.00 |
| Sep 30, 2024 | 138,000.00 |
| Jun 30, 2024 | 177,000.00 |
| Jun 30, 2024 | 177,000.00 |
| Mar 31, 2024 | 165,000.00 |
| Mar 31, 2024 | 165,000.00 |
| Dec 31, 2023 | 122,000.00 |
| Dec 31, 2023 | 122,000.00 |